Delivery Order SPE2DB22D2108-SPE2DB25FU3WG
Award Date
3/20/25
Potential Completion Date
3/21/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Losartan Potassium 100 mg tablets to the Defense Logistics Agency (DLA). The $1,327.22 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This federal contract award is for the delivery of Losartan Potassium 25mg tablets in 1000-count bottles to the Defense Logistics Agency (DLA). The $1,754.26 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is part of...
This federal contract award is for the procurement of Losartan Potassium 100 mg tablets in quantities of 1,000. The contract, valued at $6,261.50, was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 6, 2024 and is structured as a firm fixed-price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen holds...
This federal contract award is a delivery order worth $2,875.48 from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for 4,562,267,490 units of Losartan Potassium 100 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does...
This federal contract award is for the delivery of Losartan Potassium 100 mg tablets to the Defense Logistics Agency (DLA). The $2,470.56 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company that is a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 25, 2022. There was no set-aside designation, indicating the contract was awarded through full and open competition. AmerisourceBergen Drug...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,692,627 units of Losartan Potassium 100 mg tablets. The $1,811.22 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 12, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Losartan Potassium 100 mg tablets in quantities of 1,000 to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of 1,000 units of Losartan Potassium 100 mg tablets to the Defense Logistics Agency (DLA). The $3,267.34 firm fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products...
This federal contract award is for the delivery of Losartan Potassium 100 mg tablets in 1,000-count packages to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,275.23 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 10, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,063.38 firm fixed-price delivery order is for the supply of Losartan Potassium 100 mg tablets (1,000 per bottle) with a completion date of May 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...